Correspondence
Answer to the “Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure” correspondence
Respuesta a la carta «Tratamiento con glucocorticoides en pacientes con COVID-19 e insuficiencia cardíaca concurrente»
A. Salinas-Botrána,
, L.M. Pérez-Belmonteb,
, M. Méndez-Bailóna, en representación del grupo SEMI-COVID-19 Network
Corresponding author
Corresponding author
a Servicio de Medicina Interna, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria delHospital ClínicoSan Carlos (IdISSC),Madrid, Spain
b Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga (UMA), Málaga, Spain
Read
1077
Timeswas read the article
37
Total PDF
1040
Total HTML
Share statistics
array:24 [ "pii" => "S2254887422000030" "issn" => "22548874" "doi" => "10.1016/j.rceng.2021.11.001" "estado" => "S300" "fechaPublicacion" => "2022-05-01" "aid" => "1999" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Clin Esp. 2022;222:310-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0014256521002149" "issn" => "00142565" "doi" => "10.1016/j.rce.2021.11.001" "estado" => "S300" "fechaPublicacion" => "2022-05-01" "aid" => "1999" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Clin Esp. 2022;222:310-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Correspondencia</span>" "titulo" => "Respuesta a la carta «Tratamiento con glucocorticoides en pacientes con COVID-19 e insuficiencia cardíaca concurrente»" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "310" "paginaFinal" => "311" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Answer to the “Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure” correspondence" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Salinas-Botrán, L.M. Pérez-Belmonte, M. Méndez-Bailón" "autores" => array:4 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Salinas-Botrán" ] 1 => array:2 [ "nombre" => "L.M." "apellidos" => "Pérez-Belmonte" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Méndez-Bailón" ] 3 => array:1 [ "colaborador" => "en representación del grupo SEMI-COVID-19 Network" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2254887422000030" "doi" => "10.1016/j.rceng.2021.11.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887422000030?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256521002149?idApp=WRCEE" "url" => "/00142565/0000022200000005/v1_202205020519/S0014256521002149/v1_202205020519/es/main.assets" ] ] "itemAnterior" => array:19 [ "pii" => "S2254887422000042" "issn" => "22548874" "doi" => "10.1016/j.rceng.2021.11.002" "estado" => "S300" "fechaPublicacion" => "2022-05-01" "aid" => "2000" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Clin Esp. 2022;222:309-10" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Correspondence</span>" "titulo" => "Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "309" "paginaFinal" => "310" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tratamiento con glucocorticoides en pacientes con COVID-19 e insuficiencia cardíaca concurrente" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C.S. Kow, D.S. Ramachandram, S.S. Hasan" "autores" => array:3 [ 0 => array:2 [ "nombre" => "C.S." "apellidos" => "Kow" ] 1 => array:2 [ "nombre" => "D.S." "apellidos" => "Ramachandram" ] 2 => array:2 [ "nombre" => "S.S." "apellidos" => "Hasan" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256521002150" "doi" => "10.1016/j.rce.2021.11.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256521002150?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887422000042?idApp=WRCEE" "url" => "/22548874/0000022200000005/v2_202205042047/S2254887422000042/v2_202205042047/en/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S2254887421001661" "issn" => "22548874" "doi" => "10.1016/j.rceng.2021.06.004" "estado" => "S300" "fechaPublicacion" => "2022-05-01" "aid" => "1983" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Clin Esp. 2022;222:255-65" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "255" "paginaFinal" => "265" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Características clínicas y factores de riesgo de mortalidad al ingreso en pacientes con insuficiencia cardíaca hospitalizados por COVID-19 en España" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1514 "Ancho" => 1681 "Tamanyo" => 120212 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Flow diagram of the study.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Salinas-Botrán, J. Sanz-Cánovas, J. Pérez-Somarriba, L.M. Pérez-Belmonte, L. Cobos-Palacios, M. Rubio-Rivas, S. de-Cossío-Tejido, J.M. Ramos-Rincón, M. Méndez-Bailón, R. Gómez-Huelgas" "autores" => array:11 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Salinas-Botrán" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Sanz-Cánovas" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Pérez-Somarriba" ] 3 => array:2 [ "nombre" => "L.M." "apellidos" => "Pérez-Belmonte" ] 4 => array:2 [ "nombre" => "L." "apellidos" => "Cobos-Palacios" ] 5 => array:2 [ "nombre" => "M." "apellidos" => "Rubio-Rivas" ] 6 => array:2 [ "nombre" => "S." "apellidos" => "de-Cossío-Tejido" ] 7 => array:2 [ "nombre" => "J.M." "apellidos" => "Ramos-Rincón" ] 8 => array:2 [ "nombre" => "M." "apellidos" => "Méndez-Bailón" ] 9 => array:2 [ "nombre" => "R." "apellidos" => "Gómez-Huelgas" ] 10 => array:1 [ "colaborador" => "on behalf of the SEMI-COVID-19 group" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256521001417" "doi" => "10.1016/j.rce.2021.06.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256521001417?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887421001661?idApp=WRCEE" "url" => "/22548874/0000022200000005/v2_202205042047/S2254887421001661/v2_202205042047/en/main.assets" ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Correspondence</span>" "titulo" => "Answer to the “Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure” correspondence" "tieneTextoCompleto" => true "saludo" => "Dear Director," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "310" "paginaFinal" => "311" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. Salinas-Botrán, L.M. Pérez-Belmonte, M. Méndez-Bailón" "autores" => array:4 [ 0 => array:4 [ "nombre" => "A." "apellidos" => "Salinas-Botrán" "email" => array:1 [ 0 => "asalinasbotran@yahoo.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:4 [ "nombre" => "L.M." "apellidos" => "Pérez-Belmonte" "email" => array:1 [ 0 => "luismiguelpb1984@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 2 => array:3 [ "nombre" => "M." "apellidos" => "Méndez-Bailón" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:1 [ "colaborador" => "en representación del grupo SEMI-COVID-19 Network" ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria delHospital ClínicoSan Carlos (IdISSC),Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga (UMA), Málaga, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding authors." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta a la carta «Tratamiento con glucocorticoides en pacientes con COVID-19 e insuficiencia cardíaca concurrente»" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We are grateful for the comments on our article “Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain.”<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Indeed, glucocorticoid (GC) use was greater in patients with heart failure (HF) hospitalized for COVID-19 who died. This can be explained by the effects of the mineralocorticoid and sodium and water retention, as the letter’s authors correctly indicate.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Unfortunately, we do not have specific data regarding the type of GC used; the only data recorded were whether they were used or not, the dose used, and the duration of treatment (SEMI-COVID-19 Registry).<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> However, the following considerations should be noted:</p><p id="par0015" class="elsevierStylePara elsevierViewall">First, the most used GC during the first wave of the epidemic in Spain was methylprednisolone, as a recent article indicated.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Evidence on the reduction in mortality associated with the use of dexamethasone was not reported until later on<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> and as such, it was used less in our country during the first wave.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Second, the initial multivariable analysis conducted in our study included patients’ baseline clinical variables at the time of admission and did not include variables regarding treatment administered. We are currently working on a larger, more focused database in order to discern the effect of treatment, including the use of GC (especially dexamethasone) on this profile of patient.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Lastly, and in contrast to the possible deleterious effect of GC in patients with HF, it should be noted that some recent works have demonstrated the utility of other drugs in patients with HF during hospitalization for COVID-19. Patients with HF who continued treatment with renin-angiotensin-aldosterone system inhibitors during hospitalization had lower in-hospital mortality rates than those who did not receive them or in whom they were suspended.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">In conclusion, according to our results, GC should be used with caution in patients with HF, weighing their risks and benefits. More prospective, controlled studies on the use of GC in patients with HF and COVID-19 are needed to confirm these results.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Salinas-Botrán A, Pérez-Belmonte LM, Méndez-Bailón M. Respuesta a la carta «Tratamiento con glucocorticoides en pacientes con COVID-19 e insuficiencia cardíaca concurrente». Rev Clín Esp. 2022;222:311–312.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Características clínicas y factores de riesgo de mortalidad al ingreso en pacientes con insuficiencia cardíaca hospitalizados por COVID-19 en España" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Salinas-Botrán" 1 => "J. Sanz-Cánovas" 2 => "J. Pérez-Somarriba" 3 => "L.M. Pérez-Belmonte" 4 => "L. Cobos-Palacios" 5 => "M. Rubio-Rivas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rce.2021.06.004" "Revista" => array:6 [ "tituloSerie" => "Rev Clin Esp" "fecha" => "2022" "volumen" => "222" "paginaInicial" => "255" "paginaFinal" => "265" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34305156" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tratamiento con glucocorticoides en pacientes con COVID-19 e insuficiencia cardíaca concurrente" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C.S. Kow" 1 => "D.S. Ramachandram" 2 => "S.S. Hasan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rce.2021.11.002" "Revista" => array:6 [ "tituloSerie" => "Rev Clin Esp" "fecha" => "2022" "volumen" => "222" "paginaInicial" => "309" "paginaFinal" => "310" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34840340" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Características clínicas de los pacientes hospitalizados con COVID-19 en España: resultados del Registro SEMI-COVID-19" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Casas-Rojo" 1 => "J.M. Antón-Santos" 2 => "J. Millán-Núñez-Cortés" 3 => "C. Lumbreras-Bermejo" 4 => "J.M. Ramos-Rincón" 5 => "E. Roy-Vallejo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rce.2020.07.003" "Revista" => array:6 [ "tituloSerie" => "Rev Clin Esp" "fecha" => "2020" "volumen" => "220" "paginaInicial" => "480" "paginaFinal" => "494" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33994573" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.M. Pérez-Belmonte" 1 => "J. Sanz-Cánovas" 2 => "A. Salinas" 3 => "I. Sagastagoitia Fornie" 4 => "M. Méndez-Bailón" 5 => "R. Gómez-Huelgas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11739-021-02843-4" "Revista" => array:5 [ "tituloSerie" => "Intern Emerg Med" "fecha" => "2021" "paginaInicial" => "1" "paginaFinal" => "5" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32936380" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dexamethasone in hospitalized patients with Covid-19" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P. Horby" 1 => "W.S. Lim" 2 => "J.R. Emberson" 3 => "M. Mafham" 4 => "J.L. Bell" 5 => "RECOVERY Collaborative Group" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2021436" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2021" "volumen" => "384" "paginaInicial" => "693" "paginaFinal" => "704" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32678530" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adverse outcomes in patients with heart failure admitted for COVID-19 in association with renin-angiotensin-aldosterone system inhibitors" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "L.M. Pérez-Belmonte" 1 => "J. Sanz-Cánovas" 2 => "A. Salinas" 3 => "J.L. Garcia-Klepzig" 4 => "M. Méndez-Bailón" 5 => "R. Gómez-Huelgas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.20452/pamw.16126" "Revista" => array:2 [ "tituloSerie" => "Pol Arch Intern Med" "fecha" => "2021" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/22548874/0000022200000005/v2_202205042047/S2254887422000030/v2_202205042047/en/main.assets" "Apartado" => array:4 [ "identificador" => "71813" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Correspondence" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/22548874/0000022200000005/v2_202205042047/S2254887422000030/v2_202205042047/en/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887422000030?idApp=WRCEE" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 October | 16 | 0 | 16 |
| 2024 September | 19 | 0 | 19 |
| 2024 August | 21 | 0 | 21 |
| 2024 July | 22 | 0 | 22 |
| 2024 June | 15 | 0 | 15 |
| 2024 May | 23 | 0 | 23 |
| 2024 April | 21 | 0 | 21 |
| 2024 March | 11 | 0 | 11 |
| 2024 February | 11 | 0 | 11 |
| 2024 January | 17 | 0 | 17 |
| 2023 December | 16 | 0 | 16 |
| 2023 November | 38 | 0 | 38 |
| 2023 October | 25 | 0 | 25 |
| 2023 September | 33 | 3 | 36 |
| 2023 August | 23 | 0 | 23 |
| 2023 July | 29 | 0 | 29 |
| 2023 June | 30 | 0 | 30 |
| 2023 May | 42 | 6 | 48 |
| 2023 April | 28 | 0 | 28 |
| 2023 March | 25 | 2 | 27 |
| 2023 February | 22 | 0 | 22 |
| 2023 January | 26 | 0 | 26 |
| 2022 December | 31 | 1 | 32 |
| 2022 November | 37 | 0 | 37 |
| 2022 October | 32 | 2 | 34 |
| 2022 September | 28 | 0 | 28 |
| 2022 August | 32 | 3 | 35 |
| 2022 July | 34 | 1 | 35 |
| 2022 June | 53 | 0 | 53 |
| 2022 May | 136 | 6 | 142 |
| 2022 April | 39 | 7 | 46 |
| 2022 March | 25 | 3 | 28 |
| 2022 February | 55 | 3 | 58 |
| 2022 January | 25 | 0 | 25 |
Show all
